The Role of Glial Cells in Neuroinflammation, Neurodegeneration, and Neuroimmunomodulation

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 291

Special Issue Editors


E-Mail Website
Guest Editor
Department of Translational Neuroscience, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA
Interests: neuroinflammation; neurotrauma; neurodegeneration; Alzheimer's disease; Parkinson's disease; gene therapy

E-Mail Website
Guest Editor
Department of Translational Neuroscience, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA
Interests: traumatic brain injury; edema; sulphonylurea receptor 1; neurodegeneration; neuroregeneration

Special Issue Information

Dear Colleagues,

Glial cells, including astrocytes, microglia and oligodendrocytes, play a crucial role during normal homeostasis as well as in multiple neuroinflammatory disorders. The current knowledge gap due to our lack of proper understanding of the precise events and specific molecular and cellular mechanisms underlying glial–neurovascular interactions in multiple neuroinflammatory disorders is a major hurdle in the development of novel precision-targeted cellular and molecular therapies. Besides, there is a lack of adequate knowledge regarding the role of aging and sex-based differences underlying glial cell function in various neuroinflammatory and neurodegenerative disorders. Therefore, the major focus of this Special Issue is to gain novel insights into the underlying role of glial cells in various neuroinflammatory and neurodegenerative disorders, especially Alzheimer’s disease, Parkinson’s disease, stroke, traumatic brain injury, spinal cord injury, amyotrophic lateral sclerosis, frontotemporal dementia, posttraumatic stress disorder, and Huntington’s disease. We invite leading neuroscience research groups to contribute original full-length manuscripts, short reports and review articles, placing a particular emphasis on the role of glial cells in neuroinflammation, neurodegeneration, neuroregeneration, neuroplasticity, and neuroimmunomodulation, as well as motor and cognitive dysfunction. This includes discussions of vascular contributions to cognitive impairment & dementia. Studies investigating the role of glial cells using cutting-edge technologies like single-cell transcriptomics, molecular imaging, novel drug discovery, CRISPR, transgenic and knockout mice, iPS cells, stem cells, direct in vivo reprogramming of glial cells into neuronal lineage, gene therapy, gut microbiome axis, mitochondrial dysfunction, exosomes, as well as noncoding RNAs are of particular interest. Additionally, we welcome articles focused on deciphering the role of aging and sex-based differences underlying glial cell responses in various neuroinflammatory and neurodegenerative disorders.

Dr. Sudhanshu P. Raikwar
Dr. Anupama Rani
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop